ALEXTAN

Serial Number 79314817
Registration 6805598
700

Registration Progress

Application Filed
May 20, 2021
Under Examination
Approved for Publication
May 17, 2022
Published for Opposition
May 17, 2022
Registered
Aug 2, 2022

Basic Information

Serial Number
79314817
Registration Number
6805598
Filing Date
May 20, 2021
Registration Date
August 2, 2022
Published for Opposition
May 17, 2022
Drawing Code
5

Status Summary

Current Status
Active
Status Code
700
Status Date
Aug 2, 2022
Registration
Registered
Classes
005

Rights Holder

INDENA SPA

35
Address
Viale Ortles, 12
I-20139 MILANO
IT

Ownership History

INDENA SPA

Original Applicant
35
IT

INDENA SPA

Owner at Publication
35
IT

INDENA SPA

Original Registrant
35
IT

Legal Representation

Attorney
Stewart J. Bellus
USPTO Deadlines 1 active 1 overdue
Deadline Type Event Code Deadline Date Days Until Priority Extension Available
OPPOSITION
Notice of Publication
NPUB Jun 16, 2022 1117 days overdue Medium Until Jul 16, 2022

Application History

35 events
Date Code Type Description
Apr 26, 2024 RNWL P INTERNATIONAL REGISTRATION RENEWED
May 30, 2023 NREP P NEW REPRESENTATIVE AT IB RECEIVED
May 18, 2023 NREP P NEW REPRESENTATIVE AT IB RECEIVED
Mar 14, 2023 FINP P FINAL DECISION TRANSACTION PROCESSED BY IB
Nov 9, 2022 XXSS O GENERIC MADRID TRANSACTION SENT TO IB
Nov 9, 2022 XXCR P GENERIC MADRID TRANSACTION CREATED
Nov 2, 2022 FICR P FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Aug 2, 2022 NRCC E NOTICE OF REGISTRATION CONFIRMATION EMAILED
Aug 2, 2022 R.PR A REGISTERED-PRINCIPAL REGISTER
May 23, 2022 GPNX P NOTIFICATION PROCESSED BY IB
May 17, 2022 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
May 17, 2022 PUBO A PUBLISHED FOR OPPOSITION
Apr 27, 2022 OPNS P NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Apr 27, 2022 OP2R P NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Apr 27, 2022 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Apr 14, 2022 FIXD O ELECTRONIC RECORD REVIEW COMPLETE
Apr 8, 2022 ERRR O ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED
Apr 7, 2022 NREP P NEW REPRESENTATIVE AT IB RECEIVED
Apr 4, 2022 ALIE A ASSIGNED TO LIE
Apr 4, 2022 RFNT P REFUSAL PROCESSED BY IB
Apr 1, 2022 CNSA O APPROVED FOR PUB - PRINCIPAL REGISTER
Mar 31, 2022 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED
Mar 31, 2022 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE
Mar 31, 2022 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED
Mar 4, 2022 RFCS P NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Mar 4, 2022 RFRR P REFUSAL PROCESSED BY MPU
Feb 5, 2022 RFCR E NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Feb 4, 2022 CNRT R NON-FINAL ACTION WRITTEN
Feb 1, 2022 DOCK D ASSIGNED TO EXAMINER
Nov 3, 2021 NREP P NEW REPRESENTATIVE AT IB RECEIVED
Jul 20, 2021 MAFR O APPLICATION FILING RECEIPT MAILED
Jul 19, 2021 NREP P NEW REPRESENTATIVE AT IB RECEIVED
Jul 15, 2021 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jul 12, 2021 LIMI I LIMITATION FROM ORIGINAL APPLICATION ENTERED
Jul 1, 2021 SDRC M SN ASSIGNED FOR SECT 66A SUBSEQ DESIG FROM IB

Detailed Classifications

Class 005
Pharmaceutical preparations containing extracts and active principles from medicinal plants for the treatment of disorders of the cardiovascular system, gastrointestinal and respiratory systems, for the immune and endocrine systems and for the treatment of viral diseases

Classification

International Classes
005